中文 English
Other
Published in : Dec 31, 2024
Global Antimicrobial Susceptibility Testing Market Research Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2033)

Version Type

Contact us for more information
Email: market@lookwhole.com
  • 5400USD
  • 4200USD
  • 3880USD
  • 5400USD

Report Summary Catalogue Methodological


Definition and Scope:
Antimicrobial Susceptibility Testing (AST) is a laboratory technique used to determine the effectiveness of specific antimicrobial agents against bacteria or fungi causing infections. It helps in guiding clinicians to choose the most appropriate treatment for patients based on the susceptibility profile of the pathogens. AST plays a crucial role in combating antimicrobial resistance by ensuring that patients receive the most effective therapy, thereby improving clinical outcomes and reducing the spread of resistant strains. This testing method is essential in healthcare settings, including hospitals, clinics, and diagnostic laboratories, to support infection control practices and antibiotic stewardship programs.
The market for Antimicrobial Susceptibility Testing is experiencing significant growth due to several key market trends and drivers. With the increasing prevalence of infectious diseases and antimicrobial resistance worldwide, there is a growing demand for rapid and accurate diagnostic tools like AST to guide appropriate antibiotic therapy. Technological advancements in AST methods, such as automation, miniaturization, and the development of rapid molecular techniques, are driving market growth by improving testing efficiency and accuracy. Moreover, the rising awareness among healthcare providers about the importance of AST in personalized medicine and precision healthcare is further fueling market expansion. Additionally, government initiatives and regulations promoting the judicious use of antibiotics are encouraging the adoption of AST in clinical practice, contributing to market growth.
The global Antimicrobial Susceptibility Testing market size was estimated at USD 1171.25 million in 2024, exhibiting a CAGR of 7.90% during the forecast period.
This report offers a comprehensive analysis of the global Antimicrobial Susceptibility Testing market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Antimicrobial Susceptibility Testing market.
Global Antimicrobial Susceptibility Testing Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Antimicrobial Susceptibility Testing market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Antimicrobial Susceptibility Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Biomérieux
Danaher
BD
Thermo Fisher
Bio-Rad
Hi-Media
Merlin
Liofilchem
Accelerate Diagnostics
Alifax
Creative Diagnostics
Merck Group
Synbiosis
Bioanalyse
Zhuhai Dl Biotech
Market Segmentation by Type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing
Market Segmentation by Application
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
Geographic Segmentation North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Antimicrobial Susceptibility Testing Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antimicrobial Susceptibility Testing Market Definition
1.2 Antimicrobial Susceptibility Testing Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
2 Executive Summary
2.1 Global Antimicrobial Susceptibility Testing Market Size
2.2 Market Segmentation – by Type
2.3 Market Segmentation – by Application
2.4 Market Segmentation – by Geography
3 Key Market Trends, Opportunity, Drivers and Restraints
3.1 Key Takeway
3.2 Market Opportunities & Trends
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Major Factor Assessment
4 Global Antimicrobial Susceptibility Testing Market Competitive Landscape
4.1 Global Antimicrobial Susceptibility Testing Sales by Manufacturers (2020-2025)
4.2 Global Antimicrobial Susceptibility Testing Revenue Market Share by Manufacturers (2020-2025)
4.3 Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 New Entrant and Capacity Expansion Plans
4.5 Mergers & Acquisitions
5 Global Antimicrobial Susceptibility Testing Market by Region
5.1 Global Antimicrobial Susceptibility Testing Market Size by Region
5.1.1 Global Antimicrobial Susceptibility Testing Market Size by Region
5.1.2 Global Antimicrobial Susceptibility Testing Market Size Market Share by Region
5.2 Global Antimicrobial Susceptibility Testing Sales by Region
5.2.1 Global Antimicrobial Susceptibility Testing Sales by Region
5.2.2 Global Antimicrobial Susceptibility Testing Sales Market Share by Region
6 North America Market Overview
6.1 North America Antimicrobial Susceptibility Testing Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Antimicrobial Susceptibility Testing Market Size by Type
6.3 North America Antimicrobial Susceptibility Testing Market Size by Application
6.4 Top Players in North America Antimicrobial Susceptibility Testing Market
7 Europe Market Overview
7.1 Europe Antimicrobial Susceptibility Testing Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.1.6 Sweden Market Overview
7.1.7 Denmark Market Overview
7.1.8 Netherlands Market Overview
7.1.9 Switzerland Market Overview
7.1.10 Belgium Market Overview
7.1.11 Russia Market Overview
7.2 Europe Antimicrobial Susceptibility Testing Market Size by Type
7.3 Europe Antimicrobial Susceptibility Testing Market Size by Application
7.4 Top Players in Europe Antimicrobial Susceptibility Testing Market
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Australia Market Overview
8.1.6 Indonesia Market Overview
8.1.7 Malaysia Market Overview
8.1.8 Philippines Market Overview
8.1.9 Singapore Market Overview
8.1.10 Thailand Market Overview
8.1.11 Rest of APAC Market Overview
8.2 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Type
8.3 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Application
8.4 Top Players in Asia-Pacific Antimicrobial Susceptibility Testing Market
9 South America Market Overview
9.1 South America Antimicrobial Susceptibility Testing Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Antimicrobial Susceptibility Testing Market Size by Type
9.3 South America Antimicrobial Susceptibility Testing Market Size by Application
9.4 Top Players in South America Antimicrobial Susceptibility Testing Market
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Antimicrobial Susceptibility Testing Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Antimicrobial Susceptibility Testing Market Size by Type
10.3 Middle East and Africa Antimicrobial Susceptibility Testing Market Size by Application
10.4 Top Players in Middle East and Africa Antimicrobial Susceptibility Testing Market
11 Antimicrobial Susceptibility Testing Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Antimicrobial Susceptibility Testing Sales Market Share by Type (2020-2033)
11.3 Global Antimicrobial Susceptibility Testing Market Size Market Share by Type (2020-2033)
11.4 Global Antimicrobial Susceptibility Testing Price by Type (2020-2033)
12 Antimicrobial Susceptibility Testing Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Antimicrobial Susceptibility Testing Market Sales by Application (2020-2033)
12.3 Global Antimicrobial Susceptibility Testing Market Size (M USD) by Application (2020-2033)
12.4 Global Antimicrobial Susceptibility Testing Sales Growth Rate by Application (2020-2033)
13 Company Profiles
13.1 Biomérieux
13.1.1 Biomérieux Company Overview
13.1.2 Biomérieux Business Overview
13.1.3 Biomérieux Antimicrobial Susceptibility Testing Major Product Offerings
13.1.4 Biomérieux Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.1.5 Key News
13.2 Danaher
13.2.1 Danaher Company Overview
13.2.2 Danaher Business Overview
13.2.3 Danaher Antimicrobial Susceptibility Testing Major Product Offerings
13.2.4 Danaher Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.2.5 Key News
13.3 BD
13.3.1 BD Company Overview
13.3.2 BD Business Overview
13.3.3 BD Antimicrobial Susceptibility Testing Major Product Offerings
13.3.4 BD Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.3.5 Key News
13.4 Thermo Fisher
13.4.1 Thermo Fisher Company Overview
13.4.2 Thermo Fisher Business Overview
13.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Major Product Offerings
13.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.4.5 Key News
13.5 Bio-Rad
13.5.1 Bio-Rad Company Overview
13.5.2 Bio-Rad Business Overview
13.5.3 Bio-Rad Antimicrobial Susceptibility Testing Major Product Offerings
13.5.4 Bio-Rad Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.5.5 Key News
13.6 Hi-Media
13.6.1 Hi-Media Company Overview
13.6.2 Hi-Media Business Overview
13.6.3 Hi-Media Antimicrobial Susceptibility Testing Major Product Offerings
13.6.4 Hi-Media Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.6.5 Key News
13.7 Merlin
13.7.1 Merlin Company Overview
13.7.2 Merlin Business Overview
13.7.3 Merlin Antimicrobial Susceptibility Testing Major Product Offerings
13.7.4 Merlin Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.7.5 Key News
13.8 Liofilchem
13.8.1 Liofilchem Company Overview
13.8.2 Liofilchem Business Overview
13.8.3 Liofilchem Antimicrobial Susceptibility Testing Major Product Offerings
13.8.4 Liofilchem Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.8.5 Key News
13.9 Accelerate Diagnostics
13.9.1 Accelerate Diagnostics Company Overview
13.9.2 Accelerate Diagnostics Business Overview
13.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Major Product Offerings
13.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.9.5 Key News
13.10 Alifax
13.10.1 Alifax Company Overview
13.10.2 Alifax Business Overview
13.10.3 Alifax Antimicrobial Susceptibility Testing Major Product Offerings
13.10.4 Alifax Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.10.5 Key News
13.11 Creative Diagnostics
13.11.1 Creative Diagnostics Company Overview
13.11.2 Creative Diagnostics Business Overview
13.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Major Product Offerings
13.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.11.5 Key News
13.12 Merck Group
13.12.1 Merck Group Company Overview
13.12.2 Merck Group Business Overview
13.12.3 Merck Group Antimicrobial Susceptibility Testing Major Product Offerings
13.12.4 Merck Group Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.12.5 Key News
13.13 Synbiosis
13.13.1 Synbiosis Company Overview
13.13.2 Synbiosis Business Overview
13.13.3 Synbiosis Antimicrobial Susceptibility Testing Major Product Offerings
13.13.4 Synbiosis Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.13.5 Key News
13.14 Bioanalyse
13.14.1 Bioanalyse Company Overview
13.14.2 Bioanalyse Business Overview
13.14.3 Bioanalyse Antimicrobial Susceptibility Testing Major Product Offerings
13.14.4 Bioanalyse Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.14.5 Key News
13.15 Zhuhai Dl Biotech
13.15.1 Zhuhai Dl Biotech Company Overview
13.15.2 Zhuhai Dl Biotech Business Overview
13.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Major Product Offerings
13.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Sales and Revenue fromAntimicrobial Susceptibility Testing (2020-2025)
13.15.5 Key News
13.15.6 Key News
14 Key Market Trends, Opportunity, Drivers and Restraints
14.1 Key Takeway
14.2 Market Opportunities & Trends
14.3 Market Drivers
14.4 Market Restraints
14.5 Market Major Factor Assessment
14.6 Porter's Five Forces Analysis of Antimicrobial Susceptibility Testing Market
14.7 PEST Analysis of Antimicrobial Susceptibility Testing Market
15 Analysis of the Antimicrobial Susceptibility Testing Industry Chain
15.1 Overview of the Industry Chain
15.2 Upstream Segment Analysis
15.3 Midstream Segment Analysis
15.3.1 Manufacturing, Processing or Conversion Process Analysis
15.3.2 Key Technology Analysis
15.4 Downstream Segment Analysis
15.4.1 Downstream Customer List and Contact Details
15.4.2 Customer Concerns or Preference Analysis
16 Conclusion
17 Appendix
17.1 Methodology
17.2 Research Process and Data Source
17.3 Disclaimer
17.4 Note
17.5 Examples of Clients
17.6 Disclaimer
Research Methodology
The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.


Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.
Research Process
The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research.
Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).